Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 22, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Olivia Brayer Maintained (VRTX) at Buy with Increased Target to $480 on, Jul 22nd, 2024
Olivia Brayer of Cantor Fitzgerald, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $440 to $480 on, Jul 22nd, 2024.
Olivia has made no other calls on VRTX in the last 4 months.
There are 14 other peers that have a rating on VRTX. Out of the 14 peers that are also analyzing VRTX, 3 agree with Olivia's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $455 on, Thursday, July 11th, 2024
- Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $421 on, Tuesday, June 11th, 2024
- Joseph Stringer of "Needham" Reiterated at Hold on, Tuesday, May 7th, 2024
These are the ratings of the 11 analyists that currently disagree with Olivia
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $500 on, Friday, July 19th, 2024
- Steve Chesney of "Redburn Atlantic" Initiated at Strong Buy and Held Target at $545 on, Thursday, June 27th, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $555 on, Monday, June 24th, 2024
- Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Increased Target to $550 on, Monday, June 17th, 2024
- Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $500 on, Friday, May 31st, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $456 on, Tuesday, May 7th, 2024
- Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $450 on, Thursday, April 18th, 2024
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $466 on, Wednesday, April 17th, 2024
- Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $500 on, Monday, April 15th, 2024
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell and Held Target at $371 on, Friday, April 12th, 2024
- Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $438 on, Thursday, April 11th, 2024
